Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K

Many pharmaceutical agents not only require microbial metabolism for increased bioavailability and bioactivity, but also have direct effects on gut microbial assemblage and function. We examined the possibility that these actions are not mutually exclusive and may be mutually reinforcing in ways tha...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmacol Res Perspect
Päätekijät: Hasebe, Takumu, Ueno, Nobuhiro, Musch, Mark W., Nadimpalli, Anuradha, Kaneko, Atsushi, Kaifuchi, Noriko, Watanabe, Junko, Yamamoto, Masahiro, Kono, Toru, Inaba, Yuhei, Fujiya, Mikihiro, Kohgo, Yutaka, Chang, Eugene B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2016
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777267/
https://ncbi.nlm.nih.gov/pubmed/26977303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.215
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia